| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.05 |